dsRNA for treating viral infection

Details for Australian Patent Application No. 2012202689 (hide)

Owner Novartis AG

Inventors Labow, Mark Aron; Gaither, Larry Alexander; Borawski, Jason

Agent Davies Collison Cave

Pub. Number AU-A-2012202689

Parent 2008270209

Filing date 8 May 2012

Wipo publication date 31 May 2012

International Classifications

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

24 May 2012 Complete Application Filed

31 May 2012 Application Open to Public Inspection

  Published as AU-A-2012202689

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012202690-Fluid evacuator system

2012202688-Emergency power supply device and method for supplying emergency power